Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126936581 | 12693658 | 1 | I | 20160702 | 0 | 20160826 | 20160826 | DIR | 55.00 | YR | M | N | 0.00000 | 20160824 | N | PH | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126936581 | 12693658 | 1 | PS | RAPAMUNE | SIROLIMUS | 1 | Oral | 5 TABLETS QD PO | D | D | J67419 | 20170131 | 0 | 5 | DF | COATED TABLET | QD | ||
| 126936581 | 12693658 | 3 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
| 126936581 | 12693658 | 5 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 126936581 | 12693658 | 7 | C | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126936581 | 12693658 | 1 | Renal transplant |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126936581 | 12693658 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126936581 | 12693658 | Gallbladder obstruction | |
| 126936581 | 12693658 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126936581 | 12693658 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126936581 | 12693658 | 1 | 20150331 | 0 |